Home › Funds › ACT Capital Partners, L.P. › ARCT

ACT Capital Partners, L.P. position in ARCT

ARCTURUS THERAPEUTICS HLDGS · Health Care

ACT Capital Partners, L.P. reported holding 22,500 shares of ARCT (ARCTURUS THERAPEUTICS HLDGS) in its Q3 2026 13F filing — a position valued at US$308K, representing 0.21% of its reported portfolio and ranking #42 among its reported holdings. ACT Capital Partners, L.P. first reported this position in Q3 2026.

Latest position (Q3 2026)22.50K sh
Reported value held$308.02K
Portfolio Weight0.21%
First reportedQ3 2026
Last changeNew
Updated2026-11-07

Last updated: 2026-11-07 · Source: SEC EDGAR Form 13F-HR

How ACT Capital Partners, L.P.'s ARCT position evolved

ACT Capital Partners, L.P. first disclosed a stake in ARCT in Q3 2026 at 22,500 shares (US$308K).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 22.50K $308.02K New

About ARCT and 13F data

ARCT (ARCTURUS THERAPEUTICS HLDGS) is a Health Care company. 17 other funds we track also report a position in ARCT. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ARCT

No other tracked fund reports a position in ARCT.

All ARCT fund holders →

FAQ

How long has ACT Capital Partners, L.P. held ARCT?

ACT Capital Partners, L.P. has disclosed ARCT holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is ACT Capital Partners, L.P.'s current position in ARCT?

As of Q3 2026, ACT Capital Partners, L.P. holds 22.50K shares of ARCT (ARCTURUS THERAPEUTICS HLDGS), valued at $308.02K, representing 0.21% of its reported portfolio and ranking #42.

Has ACT Capital Partners, L.P. been buying or selling ARCT?

In the latest 13F filing (Q3 2026), ACT Capital Partners, L.P. newly opened its position in ARCT.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.